About LJPC-501

LJPC-501 is a peptide agonist of the renin-angiotensin system that acts to help the kidneys balance body fluids and electrolytes. Studies have shown that LJPC-501 may improve renal function in patients with HRS.


FDA has accepted our IND to study LJPC-501 in HRS. A Phase 1 clinical trial is planned to start during Q4 2013.